Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 23334921)

1.

Transport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules.

Jiang Y, Arase N, Kohyama M, Hirayasu K, Suenaga T, Jin H, Matsumoto M, Shida K, Lanier LL, Saito T, Arase H.

Int Immunol. 2013 Apr;25(4):235-46. doi: 10.1093/intimm/dxs155. Epub 2013 Jan 18.

2.

Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.

Brachet V, Péhau-Arnaudet G, Desaymard C, Raposo G, Amigorena S.

Mol Biol Cell. 1999 Sep;10(9):2891-904.

3.

Impaired processing and presentation by MHC class II proteins in human diabetic cells.

Yan G, Shi L, Penfornis A, Faustman DL.

J Immunol. 2003 Jan 1;170(1):620-7.

4.

Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.

Zechel MA, Chaturvedi P, Lee-Chan EC, Rider BJ, Singh B.

J Immunol. 1996 Jun 1;156(11):4232-9.

PMID:
8666792
5.

The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules.

Elliott EA, Drake JR, Amigorena S, Elsemore J, Webster P, Mellman I, Flavell RA.

J Exp Med. 1994 Feb 1;179(2):681-94.

6.
7.

Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.

Reber AJ, Turnquist HR, Thomas HJ, Lutz CT, Solheim JC.

Immunogenetics. 2002 May;54(2):74-81. Epub 2002 Mar 23.

PMID:
12037599
10.

Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.

Neumann J, Eis-Hübinger AM, Koch N.

J Immunol. 2003 Sep 15;171(6):3075-83.

11.

HLA-DM can partially replace the invariant chain for HLA-DR transport and surface expression in transfected endocrine epithelial cells.

Serradell L, Muntasell A, Catálfamo M, Martí M, Costa M, de Préval C, Jaraquemada D.

Tissue Antigens. 1999 May;53(5):447-58.

PMID:
10372540
12.

Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation.

Lankar D, Vincent-Schneider H, Briken V, Yokozeki T, Raposo G, Bonnerot C.

J Exp Med. 2002 Feb 18;195(4):461-72.

14.
15.

HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides.

Muntasell A, Carrascal M, Serradell L, Veelen Pv Pv, Verreck F, Koning F, Raposo G, Abián J, Jaraquemada D.

J Immunol. 2002 Nov 1;169(9):5052-60.

16.

Peptide loading in the endoplasmic reticulum accelerates trafficking of peptide:MHC class II complexes in B cells.

Morkowski S, Raposo G, Geuze HJ, Rudensky AY.

J Biomed Sci. 1999 Jan;6(1):53-63.

PMID:
9933743
17.
18.

Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.

Weenink S, Averdunk H, Boston T, Boswarva V, Guery JC, Adorini L, Mellins E, McCluskey J, Gautam AM.

Int Immunol. 1997 Jun;9(6):889-96.

20.

MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.

Gregers TF, Fleckenstein B, Vartdal F, Roepstorff P, Bakke O, Sandlie I.

Int Immunol. 2003 Nov;15(11):1291-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk